中文

Investor Relations

Home > Investor Relations

Information Disclosure
Announcements and Circulars Listing Documents Financial Reports
  1. 2024-12-10

    VOLUNTARY ANNOUNCEMENT - PHASE II STUDY UPDATED DATA OF M701 FOR MALIGNANT ASCITES PRESENTED AT THE ESMO-ASIA CONGRESS 2024
  2. 2024-12-04

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024
  3. 2024-11-05

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024
  4. 2024-10-22

    Articles of Association
  5. 2024-10-22

    LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
  6. 2024-10-22

    POLL RESULTS OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024 HELD ON TUESDAY, OCTOBER 22, 2024
  7. 2024-10-08

    INSIDE INFORMATION - LICENSE AND COLLABORATION AGREEMENT WITH CT TIANQING FOR M701
  8. 2024-10-04

    Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024
  9. 2024-09-30

    FORM OF PROXY FOR THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024
  10. 2024-09-30

    NOTICE OF THE FIRST EXTRAORDINARY GENERAL MEETING OF 2024
<123456789
Home About YZYBIO Science and Technology Products and Research Investor Relations News Careers
Phone：
027-82668988

E-Mail：info@yzybio.com

Address：Biolake, C2-1, No. 666 High-tech Avenue, Wuhan, Hubei, China

Share
Copyright ©2014-2022 YOUZHIYOU All rights reserved 鄂ICP备2022016887号-1